Urologic Oncologists Seldom Perform Female Organ- and Nerve-Sparing Radical Cystectomy
Provider training on female reproductive organ-sparing and nerve-sparing radical cystectomy needs to improve, according to investigators.
Provider training on female reproductive organ-sparing and nerve-sparing radical cystectomy needs to improve, according to investigators.
Swedish studies reveal significantly elevated risks for myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.
Trend may reflect increasing use of systemic immunotherapies as first-line treatments, according to investigators.
Aortic calcification may lead to arterial degradation that increases the risk for acute kidney injury, according to investigators.
Findings are from a case series of men who underwent cystoprostatectomy in China.
Pembrolizumab demonstrated antitumor activity in patients with high-risk, papillary NMIBC who did not undergo radical cystectomy and did not respond to BCG.
Study findings fill in the evidence gap during the current BCG shortage, while data from randomized clinical trials are pending.
Sacituzumab govitecan has demonstrated activity in patients with platinum-ineligible metastatic urothelial carcinoma whose disease progressed after checkpoint inhibitor therapy.
Neoadjuvant chemotherapy prior to radical cystectomy is not associated with an increased risk for major complications vs radical cystectomy alone, but it does increase the risk for bleeding requiring transfusion and sepsis.
Investigators reported 90- and 450-day complete response rates of 53% and 28%, respectively, according to interim results from a phase 2 trial.